Aberg-Wistedt, A., Martensson, B., Bertilsson, L. & Malmgren, R. (1986) Electroconvulsive therapy effects on cerebrospinal fluid monoamine metabolites and platelet serotonin uptake in melancholia. Convulsive Therapy, 2, 91–98.
Abrams, R. (1982) Clinical prediction of ECT response in depressed patients. Psychopharmacology Bulletin, 18, 48–50.
Abrams, R. & Swartz, C. M. (1985) Electroconvulsive therapy and prolactin release: correlation to treatment response in melancholia. Convulsive Therapy, 1, 38–42.
Albala, A. A., Greden, J. F., Tarika, J. & Carroll, B. J. (1981) Changes in serial dexamethasone suppression tests among unipolar depressives receiving electroconvulsive therapy. Biological Psychiatry, 16, 551–560.
Albala, A. A., Haskett, R. F. & Greden, J. F. (1984) Neuroendocrine markers in the practice of ECT. In ECT: Basic Mechanisms (eds Lerer, B., Weiner, R. D. & Belmaker, R. H.). London: John Libbey.
Alexopoulos, J. S., Inturrisi, C. E., Lipman, R., Frances, R., Haycocks, J., Dougherty, J. H. & Rossier, J. (1983) Plasma immunoreactive beta-endorphin levels in depression: effects of electroconvulsive therapy. Archives of General Psychiatry, 40, 181–183.
American Psychiatric Association (1978) Electroconvulsive Therapy, Task Force Report 14. Washington: APA.
Aperia, B., Thoren, N. & Wetterberg, L. (1985) Prolactin and thyrotropin in serum during electroconvulsive therapy in patients with major depressive illness. Acta Psychiatrica Scandinavica, 72, 302–308.
Arana, G. W., Baldessarini, R. J. & Ornsteen, N. (1985) The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Archives of General Psychiatry, 42, 1193–1204.
Balldin, J. (1982) Factors influencing prolactin release induced by electroconvulsive therapy. Acta Psychiatrica Scandinavica, 65, 365–369.
Balldin, J., Granerus, A. K., Lindstedt, J., Modigh, K. & Walinder, J. (1982) Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Psychopharmacology, 76, 371–376.
Barkai, A. I. & Nelson, H. D. (1987) Alterations by antidepressants of cerebrospinal fluid formation and calcium distribution dynamics in the intact rat brain. Biological Psychiatry, 22, 892–898.
Carman, J. S., Post, R. M., Goodwin, F. K. & Bunney, W. E. (1977) Calcium and electroconvulsive therapy of severe depressive illness. Biological Psychiatry, 12, 5–17.
Carney, M. W. P., Roth, M. & Garside, R. F. (1965) The diagnosis of depressive syndromes and the prediction of ECT response. British Journal of Psychiatry, 111, 659–674.
Carroll, B. J., Mendels, J. & Sugarman, A. A. (1976a) Urinary free cortisol excretion in depression. Psychological Medicine, 6, 43–50.
Carroll, B. J., Curtis, J. C. & Mendels, J. (1976b) Cerebrospinal fluid and plasma free Cortisol concentrations in depression. Psychological Medicine, 6, 235–244.
Carroll, B. J., Curtis, J. C. & Mendels, J. (1976c) Neuroendocrine regulation in depression – I. Limbic system – adrenocortical dysfunction. Archives of General Psychiatry, 33, 1039–1044.
Carroll, B. J., Feinbero, M., Greden, J. F., Tarika, J., Albala, A. A., Haskett, R. F., James, N. M., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J. P. & Young, E. (1981) A specific laboratory test for the diagnosis of melancholia: standardisation, validation, and clinical utility. Archives of General Psychiatry, 38, 15–22.
Checkley, S. A. (1980) Neuroendocrine tests of monoamine function in man: a review of basic theory and its applications to the study of depressive illness. Psychological Medicine, 10, 35–53.
Christie, J. E., Whalley, L. J., Brown, N. S. & Dick, H. (1982) Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients. British Journal of Psychiatry, 140, 268–273.
Christie, J. E., Whalley, L. J.
Dick, H., Blackwood, D. H. R., Blackburn, I. M. & Fink, G. (1986) Raised plasma cortisol concentrations a feature of drug-free psychotics and not specific for depression. British Journal of Psychiatry, 148, 58–65.
Cooper, S. J., Kelly, J. G. & King, D. J. (1985) Adrenergic receptors in depression: effects of electroconvulsive therapy. British Journal of Psychiatry, 147, 23–29.
Coppen, A., Rao, R., Bishop, M., Abou-Saleh, M. T. & Wood, K. (1980a) Neuroendocrine studies in affective disorders – Part 1. Plasma prolactin response to thyrotropin-releasing hormone in affective disorders: effect of ECT. Journal of Affective Disorders, 2, 311–315.
Coppen, A., Rao, R., Bishop, M., Abou-Saleh, M. T. & Wood, K. (1980b) Neuroendocrine studies in affective disorders – Part 2. Plasma thyroid-stimulating hormone response to thyrotropin-releasing hormone in affective disorders: effect of ECT. Journal of Affective Disorders, 2, 317–320.
Coryell, W. (1982) Hypothalamic-pituitary-adrenal axis abnormality and ECT response. Psychiatry Research, 6, 283–291.
Coryell, W. (1986) Are serial dexamethasone suppression tests useful in electroconvulsive therapy?
Journal of Affective Disorders, 10, 59–66.
Coryell, W. & Zimmerman, M. (1983) The dexamethasone suppression test and ECT outcome: a six-month followup. Biological Psychiatry, 18, 21–27.
Coryell, W. & Zimmerman, M. (1984) Outcome following ECT for primary unipolar depression: a test of newly proposed response predictors. American Journal of Psychiatry, 141, 862–867.
Costain, D. W., Cowen, P. J., Gelder, M. G. & Grahame-Smith, D. G. (1982) Electroconvulsive therapy in the brain: evidence for increased dopamine-mediated responses. Lancet, ii, 400–404.
Cowen, P. J. (1986) Neuroendocrine responses as a probe into the mechanisms of action of electroconvulsive therapy. Annals of the New York Academy of Sciences, 462, 163–171.
Crow, T. J., Deakin, J. F. W., Johnstone, E. C., MacMillan, J. F., Owens, D. G. C., Lawler, P., Frith, C. D., Stevens, M. & McPherson, K. (1984) The Northwick Park ECT Trial: predictors of response to real and simulated ECT. British Journal of Psychiatry, 144, 227–237.
Deakin, J. F. W., Ferrier, I. N., Crow, T. J., Johnstone, E. C. & Lawler, P. (1983) Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome. British Journal of Psychiatry, 143, 618–624.
Decina, P., Sackeim, H. A. & Malitz, S. (1983) Prognostic value of serial dexamethasone suppression tests during and following ECT. Psychopharmacology Bulletin, 19, 85–87.
Decina, P., Sackeim, H. A., Kahn, D. A., Pierson, D., Hopkins, N. & Malitz, S. (1987) Effects of ECT on the TRH stimulation test. Psychoneuroendocrinology, 12, 29–34.
D'Elia, G., Ottosson, J.-O. & Stromgren, L. S. (1983) Present practice of electroconvulsive therapy in Scandinavia. Archives of General Psychiatry, 40, 577–581.
Devanand, D. P., Decina, P., Sackeim, H. A., Hopkins, N., Novacenko, H. & Malitz, S. (1987) Serial dexamethasone suppression tests in initial suppressors and non-suppressors treated with electroconvulsive therapy. Biological Psychiatry, 22, 463–472.
Dykes, S., Scott, A. I. F., Gow, S. M. & Whalley, L. J. (1987) The effects of seizure duration on serum TSH concentration after ECT. Psychoneuroendocrinology, 12, 477–482.
Dysken, M. W., Pandey, G. N., Chan, S. S., Hicks, R. & Davis, J. M. (1979) Serial post-dexamethasone cortisol levels in a patient undergoing ECT. American Journal of Psychiatry, 136, 1328–1329.
Fink, M. (1979) Convulsive Therapy: Theory and Practice. New York: Raven Press.
Fink, M., Gujavarty, K. & Greenberg, L. (1987) Serial dexamethasone suppression tests and clinical outcome in ECT. Convulsive Therapy, 3, 111–120.
Flach, F. F. (1964) Calcium metabolism in states of depression. British Journal of Psychiatry, 110, 588–593.
Fragalla, F. F. & Flach, F. F. (1970) Studies of mineral metabolism in mental depression – 1. The effects of imipramine and electroconvulsive therapy on calcium balance and kinetics. Journal of Nervous and Mental Disease, 151, 120–129.
Funkenstein, D. H., Greenblatt, M. & Solomon, H. C. (1948) Autonomic nervous system changes following electric shock treatment. Journal of Nervous and Mental Disease, 108, 409–422.
Gibbons, G. L. (1964) Cortisol secretion rate in depressive illness. Archives of General Psychiatry, 10, 572–575.
Grahame-Smith, D. G., Green, A. R. & Costain, D. W. (1978) Mechanism of the antidepressant action of electroconvulsive therapy. Lancet, i, 254–257.
Greden, J. F., Albala, A. A., Haskett, R. F., James, N. M., Goodman, L., Steiner, M. & Carroll, B. J. (1980) Normalisation of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. Biological Psychiatry, 15, 449–458.
Hamilton, M. (1986) Electroconvulsive therapy: indications and contraindications. Annals of the New York Academy of Sciences, 462, 5–11.
Havens, L. L., Zileli, M. S., DiMascio, A. & Boling, L. (1959) Changes in catecholamine response to successive electric convulsive treatments. Journal of Mental Science, 105, 821–829.
Hobson, R. F. (1953) Prognostic factors in electric convulsive therapy. Journal of Neurology, Neurosurgery and Psychiatry, 16, 275–281.
Kastin, A. J., Ehrensing, R. H., Slasch, D. S. & Anderson, M. S. (1972) Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet, ii, 740–742.
Katona, C. L. E. & Aldridge, C. R. (1984) Prediction of ECT response. Neuropharmacology, 23, 281–283.
Katona, C. L. E., Aldridge, C. R., Roth, M. & Hyde, J. (1987) The dexamethasone suppression test and prediction of outcome in patients receiving ECT. British Journal of Psychiatry, 150, 315–318.
Kendell, R. E. (1981) The present status of electroconvulsive therapy. British Journal of Psychiatry, 139, 265–283.
Kennard, M. A. & Willner, M. D. (1948) Significance of changes in electroencephalogram which result from shock therapy. American Journal of Psychiatry, 105, 40–45.
Kirkegaard, C. & Faber, J. (1986) Influence of free thyroid hormone levels on the TSH response to TRH in endogenous depression. Psychoneuroendocrinology, 11, 491–497.
Lipman, R. S., Backup, C., Bobrin, Y., Delaplane, J. M., Doeff, J., Gittleman, S., Joseph, R. & Kanefield, M. (1986a) Dexamethasone suppression test as a predictor of response to electroconvulsive therapy – 1. Inpatient treatment. Convulsive Therapy, 2, 151–160.
Lipman, R. S., Uffner, W., Schwalb, N., Ravetz, R., Lief, B., Levy, S. & Levenberg, D. (1986b) Dexamethasone suppression test as a predictor of response to electroconvulsive therapy – 2. Six month followup. Convulsive Therapy, 2, 161–167.
Medical Research Council (1965) Clinical trial of the treatment of depressive illness. British Medical Journal, i, 881–886.
Misiaszek, J., Cork, R. C., Hameroff, S. R., Finley, J. & Weiss, J. L. (1984) The effect of electroconvulsive therapy on plasma beta endorphin. Biological Psychiatry, 19, 451–455.
Modai, I., Rinsky, H. & Cygielman, G. (1986) The DST as a predictor of acute response to treatment with ECT, chlorimipramine, amitriptyline, and phenelzine. Journal of Clinical Psychiatry, 47, 139–140.
Mosovich, A. & Katzenelbogen, S. (1948) Electroshock therapy, clinical and electroencephalographic studies. Journal of Nervous and Mental Disease, 107, 517–530.
Ottosson, J.-O. (1960) Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatrica et Neurologica Scandinavica Supplementum 145.
Ottosson, J.-O. (1962) Seizure characteristics and therapeutic efficiency in electroconvulsive therapy: an analysis of the antidepressant efficiency of grand mal and lidocaine-modified seizures. Journal of Nervous and Mental Disease, 135, 239–251.
Ottosson, J.-O. (1974) Systemic biochemical effects of ECT. In Psychobiology of Electroconvulsive Therapy (ed. Fink, M.). London: John Wiley.
Papakostas, Y., Fink, M., Lee, J., Irwin, P. & Johnson, L. (1981) Neuroendocrine measures in psychiatric patients: course and outcome with ECT. Psychiatry Research, 4, 55–64.
Prange, A. J., Wilson, I. C., Lara, P. P. & Alltop, L. B. (1972) Effects of thyrotropin-releasing hormone in depression. Lancet, ii, 999–1002.
Price, T. R. P., Mackenzie, T. B., Tucker, G. J. & Colver, C. (1978) The dose-response ratio in electroconvulsive therapy: a preliminary study. Archives of General Psychiatry, 35, 1131–1133.
Prudic, J., Sackeim, H. A., Decina, P., Hopkins, N., Roth, F. R. & Malitz, S. (1987) Acute effects of ECT on cardiovascular functioning: relations to patient and treatment variables. Acta Psychiatrica Scandinavica, 75, 344–351.
Rich, C. L. & Black, N. A. (1985) The efficiency of ECT: II. Correlation of specific treatment variables to response rate in unilateral ECT. Psychiatry Research, 16, 147–154.
Roberts, J. M. (1959) Prognostic factors in the electroshock treatment of depressive states – 2. The application of specific tests. Journal of Mental Science, 105, 703–713.
Rose, J. T. (1962) The Funkenstein test – a review of the literature. Acta Psychiatrica Scandinavica, 38, 124–153.
Roth, M., Kay, D. W. K., Shaw, J. & Green, J. (1957) Prognosis and pentothal-induced electroencephalographic changes in electroconvulsive treatment. Electroencephalography and Clinical Neurophysiology, 9, 225–237.
Roy, A., Pickar, D., Linnolia, M. & Potter, W. Z. (1985) Plasma norepinephrine level in affective disorders: relationship to melancholia. Archives of General Psychiatry, 42, 1181–1185.
Sackheim, H. A., Decina, P., Prohovnik, I. & Malitz, S. (1987a) Seizure threshold in electroconvulsive therapy. Archives of General Psychiatry, 44, 355–360.
Sackheim, H. A., Decina, P.
Portnoy, S., Neeley, P. & Malitz, S. (1987b) Studies of dosage, seizure threshold and seizure duration in ECT. Biological Psychiatry, 22, 249–268.
Schildkraut, J. J. (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry, 112, 509–522.
Scott, A. I. F., Whalley, L. J., Bennie, J. & Bowler, G. (1986) Oestrogen-stimulated neurophysin and outcome after electroconvulsive therapy. Lancet, i, 1411–1414.
Shagass, C. (1954) The sedation threshold: a method for estimating tension in psychiatric patients. Electroencephalography and Clinical Neurophysiology, 6, 221–227.
Sharma, I. J., Venkitasubramanian, T. A. & Ajnihotri, B. R. (1986) 3-MHPG as a non-predictor of antidepressant response to imipramine and electroconvulsive therapy. Acta Psychiatrica Scandinavica, 74, 252–254.
Slade, A. P. & Checkley, S. A. (1980) A neuroendocrine study of the mechanism of the action of ECT. British Journal of Psychiatry, 137, 217–221.
Small, J. G., Small, I. F. & Milstein, Z. (1978) Electrophysiology of EST. In Psychopharmacology: A Generation of Progress (eds Lipton, M. A., Di Mascio, A. & Killam, K. F.). New York: Raven Press.
Thorpe, J. G. (1962) The current status of prognostic test indicators for electroconvulsive therapy. Psychosomatic Medicine, 24, 554–568.
Weil-Malherbe, H. (1955) The effect of convulsive therapy on plasma adrenaline and noradrenaline. Journal of Mental Science, 101, 156–162.
Weiner, R. D., Rogers, H. J., Welch, C. A., Davidson, J. R. T., Miller, R. D., Weir, D., Cahill, J. F. & Squiz, L. R. (1983) ECT stimulus parameters and electrode placement: relevance to therapeutic and adverse effects. In ECT: Basic Mechanisms (eds Lerer, B., Weiner, R. & Belmaker, R.). London: John Libbey.
Weizman, A., Gil-Ad, I., Grupper, D., Tyano, S. & Laron, Z. (1987) The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients. Psychopharmacology, 93, 122–126.
Whalley, L. J., Eagles, J. M., Bowler, G. M. R., Bennie, J. G., Dick, H. R., McGuire, R. J. & Fink, G. (1987) Selective effects of ECT on hypothalamic pituitary activity. Psychological Medicine, 17, 312–328.
Whiteford, H. A., Peabody, C. A., Czernansky, J. G., Warner, M. D. & Berger, P. A. (1987) Elevated baseline and post-dexamethasone Cortisol levels: a reflection of severity or endogeneity. Journal of Affective Disorders, 12, 199–202.
Wyatt, R. J., Portnoy, B., Kupfer, D. J., Snyder, F. & Engelman, K. (1971) Resting plasma catecholamine concentrations in patients with depression and anxiety. Archives of General Psychiatry, 24, 65–70.
Zorumski, C. F., Burke, W. J., Rutherford, J. L. & Reich, T. (1986) ECT: clinical variables, seizure duration, and outcome. Convulsive Therapy, 2, 109–119.